Salomon & Ludwin’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.8K Buy
1,096
+362
+49% +$29.2K 0.01% 313
2026
Q1
$63.6K Sell
734
-303
-29% -$29K 0.01% 388
2025
Q4
$101K Buy
1,037
+142
+16% +$13.8K 0.01% 239
2025
Q3
$87.4K Buy
895
+621
+227% +$57.1K 0.01% 252
2025
Q2
$24.2K Buy
274
+56
+26% +$4.75K ﹤0.01% 360
2025
Q1
$19.6K Hold
218
﹤0.01% 364
2024
Q4
$17.4K Hold
218
﹤0.01% 375
2024
Q3
$19.6K Sell
218
-62
-22% -$5.22K ﹤0.01% 371
2024
Q2
$22K Sell
280
-200
-42% -$16.4K ﹤0.01% 350
2024
Q1
$41.8K Sell
480
-95
-17% -$8.11K ﹤0.01% 382
2023
Q4
$45.1K Hold
575
﹤0.01% 322
2023
Q3
$45.1K Buy
+575
New +$48.1K ﹤0.01% 322
2020
Q2
Sell
-91
Closed -$8K 160
2020
Q1
$8K Hold
91
﹤0.01% 174
2019
Q4
$10K Hold
91
﹤0.01% 180
2019
Q3
$10K Hold
91
﹤0.01% 167
2019
Q2
$9K Sell
91
-42
-32% -$3.83K ﹤0.01% 166
2019
Q1
$12K Buy
133
+42
+46% +$3.76K ﹤0.01% 153
2018
Q4
$8K Buy
+91
New +$8.5K ﹤0.01% 164

Other funds holding MDT

Salomon & Ludwin's MDT Position: Q2 2026 in Review

Salomon & Ludwin increased its Medtronic (MDT) stake by 49% in Q2 2026, buying an estimated $29.2K and bringing the position to 1,096 shares worth $86.8K. The position accounts for 0.01% of the portfolio, ranked #313.

Salomon & Ludwin first reported a position in MDT in Q4 2018 and has held it in 18 quarters since. The position peaked at $101K in Q4 2025. 2,141 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Salomon & Ludwin held 1,096 shares of Medtronic worth $86.8K as of Q2 2026.
  • Salomon & Ludwin bought 362 Medtronic shares in Q2 2026, an estimated $29.2K.
  • Medtronic made up 0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #313 holding.
  • Salomon & Ludwin first reported a position in Medtronic in Q4 2018 and has held it in 18 quarters since.
  • Salomon & Ludwin's Medtronic position peaked at $101K in Q4 2025.
  • 2,141 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.